Biotech And Policy News

China Drafts Export Rules to Block Foreign Acquisitions of Core Biotech Platforms

Beijing has released a draft policy to restrict the export of key biopharmaceutical technologies, specifically targeting foreign acquisitions of cell and gene therapy, siRNA, and pathogen gain-of-function platforms.